Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Macrabin-CB is an injectable nutritional supplement developed and marketed by TCF Pharmaceuticals. It is a fixed-dose combination containing methylcobalamin (vitamin B12), pyridoxine (vitamin B6), and niacinamide (vitamin B3). The product is approved and marketed for the treatment and prevention of nutritional deficiencies. Methylcobalamin acts as a coenzyme in nucleic acid synthesis and myelin formation; pyridoxine is essential for amino acid, carbohydrate, and lipid metabolism; and niacinamide is a precursor to NAD+/NADP+, which are vital for cellular energy production and macromolecular synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylcobalamin + niacinamide + pyridoxine (TCF Pharmaceuticals).